Clinical Trial Update: Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants [Phase 4]

View source ↗

Summary

Phase 4 CAST trial updating the use of Curosurf (poractant alfa) and Survanta (beractant) for respiratory distress syndrome in very premature infants; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus
• Prematurity
• Respiratory Distress Syndrome

Drugs mentioned

• Curosurf (poractant alfa)
• SURVANTA (beractant)

Snippet

Sponsor: Alan Fujii | Conditions: Prematurity, Respiratory Distress Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2011-09-20